This breakdown examines two cases that raise urgent concerns about the ethics of Black bodies in science, highlighting how power and research practices continue to affect Black communities. In Guinea-Bissau, a Trump-funded clinical trial delayed a proven hepatitis B vaccine for newborn African babies as part of a research protocol, a move critics say exposed infants to preventable risk. In the United States, a recent report found that genetic and brain-scan data from more than 20,000 children, many of them Black, was misused to support discredited race-based science. Together, the cases point to ongoing gaps in oversight and revive historical fears about unethical medical research involving Black populations.


